Posted inGenetics
Candid Therapeutics Enters into Agreement with WuXi Biologics on Trispecific T-Cell Engager
CDMO WuXi Biologics signed a deal with Candid Therapeutics, a clinical-stage biotechnology company, giving Candid exclusive global rights to a…









